Kevin Gadient is a key member of the Site Leadership Team at the Emergent BioSolutions site in Winnipeg, Manitoba, Canada. With a professional background in Chemical Engineering and years in operations-based management roles, he is the Director of Manufacturing Sciences & Technology. His department is responsible for Technology Transfer activities (drug substance, drug product & analytical Technology Transfer), Process Validation and Process Engineering. Kevin Gadient successfully led the implementation of the Vanrx SA25 aseptic workcell at Emergent BioSolutions, which achieved the worldâ€™s first regulatory approval from both Health Canada and the FDA for filling commercial, biological products onto this new technology. Kevin demonstrates a unique balance of driving results for his organization while being a leader focused on the development & personal growth of his team members. Whenever possible (and outside of a pandemic environment), Kevin continues to create & perform music with the rock band he started in high school.